Yahoo Finance

Herpes Simplex Keratitis Treatment Analysis Report 2025-2034: Market is Expanding Due to Rising HSV Infections, Increased Healthcare Spending, Telemedicine Adoption, and ...

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Herpes Simplex Keratitis Treatment Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The herpes simplex keratitis treatment ...
Investing

FDA grants platform technology designation to Krystal Biotech’s HSV-1 vector

The HSV-1 vector is currently being evaluated in a randomized placebo-controlled trial for the treatment of neurotrophic keratitis (NK), a rare degenerative corneal disease. The FDA’s platform ...
WTWO

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...
The Westside Gazette

Can Herpes Cause Blindness? Doctors Share the Truth

When former Spice Girl Mel B revealed that she was temporarily blinded in one eye due to a herpes-related complication, it shocked many fans and sparked a wave of questions about the virus’s potential ...
Medscape

Ophthalmic Medications in Pediatric Patients

Compr Ophthalmol Update. 2005;6(2):85-101. In a 10-week study of three times daily oral acyclovir against placebo, pediatric patients with HSV stromal keratitis who were treated concomitantly with ...